You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nuclear factor E2-related factor 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Healthy Trial in Groningen (Milvexian, 4-Factor Prothrombin Complex Concentrate (4F-PCC), Recombinant Human Factor VIIa

Recruiting
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jan 3, 2023

Glioblastoma Trial in Lund (Salovum, Placebo egg yolk powder)

Recruiting
  • Glioblastoma
  • Salovum
  • Placebo egg yolk powder
  • Lund, Sweden
    Skåne University Hospital
Dec 30, 2022

LSCI and Thermography for Determining Risk Factor of Developing

Not yet recruiting
  • Diabetic Foot
    • (no location specified)
    May 2, 2023

    Metabolic Disturbance, Sedentary Behavior Trial in Toronto (Experimental: Guidelines-based physical activity, Experimental:

    Recruiting
    • Metabolic Disturbance
    • Sedentary Behavior
    • Experimental: Guidelines-based physical activity
    • +2 more
    • Toronto, Ontario, Canada
      Goldring Centre for High Performance Sport
    Mar 4, 2023

    Breast Cancer Invasive Trial (pyrotinib)

    Not yet recruiting
    • Breast Cancer Invasive
    • (no location specified)
    Jun 18, 2023

    Type II Diabetes Trial in Corbeil-Essonnes (pratice physical activity)

    Recruiting
    • Type II Diabetes
    • pratice physical activity
    • Corbeil-Essonnes, France
      Centre Hospitalier Sud Francilien
    May 10, 2022

    Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)

    Recruiting
    • Primary Ovarian Insufficiency
    • Premature Ovarian Failure
    • Toronto, Ontario, Canada
      Trio Fertility
    Oct 31, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Traumatic Hemorrhage, Coagulopathy, Massive Hemorrhage Trial in Hamitlon, London, Toronto (Fibrinogen + PCC, Frozen Plasma)

    Recruiting
    • Traumatic Hemorrhage
    • +2 more
    • Fibrinogen + PCC
    • Frozen Plasma
    • Vancouver, British Columbia, Canada
    • +5 more
    Dec 1, 2022

    Metabolic Syndrome as Prognostic Factor for Outcome of Sever

    Completed
    • COVID-19
      • Cairo, Egypt
        Ain Shams University
      Jul 25, 2022

      Breast Cancer Trial (Tucatinib, Doxil)

      Not yet recruiting
      • Breast Cancer
      • (no location specified)
      Feb 17, 2023

      Worse Outcome Post-Sars-CoV-2 Infection

      Completed
      • COVID-19
      • +2 more
        • Johannesburg, Gauteng, South Africa
          The Aurum Institute
        Jan 9, 2023

        Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

        Not yet recruiting
        • Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset
        • +2 more
        • Measuring inflammatory serum biomarkers
        • (no location specified)
        Oct 4, 2022

        Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

        Not yet recruiting
        • Pleural Effusion, Malignant
        • pleural markers
        • (no location specified)
        Jan 20, 2023

        Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

        Recruiting
        • Hormone Receptor Positive HER-2 Negative Breast Cancer
        • Shanghai, Shanghai, China
          Breast cancer institute of Fudan University Cancer Hospital
        Jun 12, 2023

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +9 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +7 more
        • Duarte, California
        • +1 more
        Sep 22, 2023

        Lung Cancer Trial (TILT-123, Pembrolizumab)

        Not yet recruiting
        • Lung Cancer
        • TILT-123
        • Pembrolizumab
        • (no location specified)
        Nov 5, 2023

        Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

        Not yet recruiting
        • Nonalcoholic Steatohepatitis
        • Genetic Risk Factor
        • ALN-PNP Dose Level 1
        • +3 more
        • (no location specified)
        Sep 5, 2023

        Solid Tumor Trial (HER2-E-CART cells)

        Not yet recruiting
        • Solid Tumor
        • HER2-E-CART cells
        • (no location specified)
        Feb 16, 2023

        Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myeloid Neoplasm
        • Biospecimen Collection
        • +9 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Sep 5, 2023

        HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

        Recruiting
        • HR+/HER2- Advanced Breast Cancer
        • Targeted Therapy
        • Beijing, Beijing, China
          National Cancer Center/National Clinical Research Center for Can
        Aug 1, 2023

        Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

        Not yet recruiting
        • Neovascular Age-related Macular Degeneration (nAMD)
        • AR-14034 SR implant lower dose
        • +3 more
        • (no location specified)
        Mar 3, 2023

        Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

        Recruiting
        • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
        • Canton, Ohio
          Gabrail Cancer and Research Center
        Jul 21, 2023

        Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

        Recruiting
        • Metastatic Breast Cancer
        • +2 more
        • Ocala, Florida
          Ocala Oncology Center PL DBA Florida Cancer Affiliates
        Jul 19, 2023